One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.1551.1551
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Institut Gustave Roussy, Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, Cancer Prevention Institute of California, Sarah Cannon, Fondazione IRCCS Istituto Nazionale dei Tumori, Centre Léon Bérard, Moffitt Cancer Center, West Cancer Center, Northwestern University, Yale Cancer Center, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Princess Margaret Cancer Centre, University of TorontoCC-122 DLBCL-001: Phase Ib Study of CC-122 Plus Rituximab in Patients with Chemo-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
